申请人:NAVIRE PHARMA, INC.
公开号:US20210317122A1
公开(公告)日:2021-10-14
The present invention relates to compounds which may be useful as inhibitors of PTPN11 for the treatment or prevention of cancer and other PTP-mediated diseases. Disclosed herein are new compounds and compounds based on pyrazolopyrazines and their application as pharmaceuticals for the treatment of disease.